Possible treatment for COVID-19 related respiratory failure

Jonathan Javitt, CEO of NeuroRx, discusses his collaboration with Relief Therapeutics on Aviptadil, a synthetic version of vasoactive intestinal peptide, and a potential treatment of COVID-19 related respiratory failure.